Skip to content

Academic Breast Cancer Consortium (ABRCC)

Collaboration & Innovation in Cancer Research

The Academic Breast Cancer Consortium (ABRCC) is represented by Key Opinion Leaders (KOLs) and Top Investigators at the most prestigious institutions in the USA and Canada. 
It provides a platform on which to design and develop state of the art targeted and combination studies for cancer drug treatments.

"ABRCC is an academic consortium formed for the new era of clinical trial design and implementation. Our goal is to rapidly translate advances in breast cancer research into targeted therapies that will benefit our patients."

Peter Kabos, MD, ABRCC Director
Academic Breast Cancer Consortium (ABRCC)